PET/MRI在乳腺癌诊疗方面的应用OA
Application of PET/MRI in the diagnosis and treatment of breast cancer
乳腺癌是女性最常见的恶性肿瘤之一,其发病率和死亡率逐年升高,对乳腺癌患者开展早期精确诊断与治疗是改善患者预后的关键.一体化正电子发射断层扫描/磁共振成像(positron emission tomography/magnetic resonance imaging,PET/MRI)作为一种新兴的多模态分子影像技术,融合了PET的分子代谢成像和MRI的高分辨率软组织成像优势,能够以更高清晰度识别肿瘤及其与周边组织的关系,在乳腺癌的诊疗过程中有着重要的临床意义.文章旨在对PET/MRI在乳腺癌诊断、分期、分子分型及疗效监测等方面的应用及进展进行综述.
Breast cancer is one of the most common malignant tumors in women,with its incidence and mortality rates increasing annually.Early and accurate diagnosis and treatment of breast cancer patients are crucial for improving prognosis.Integrated positron emission tomography/magnetic resonance imaging(PET/MRI)as an emerging multimodal molecular imaging technology,combines the molecular metabolic imaging capabilities of PET with the high-resolution soft tissue imaging advantages of MRI.This allows for clearer identification of tumors and their relationships with surrounding tissues,holding significant clinical importance in the diagnosis and treatment of breast cancer.This article primarily reviews the applications and advancements of PET/MRI in the diagnosis,staging,molecular typing,and treatment monitoring of breast cancer.
BIAN Yumeng;DING Ziteng;TANG Lijun;LI Tiannü
Department of Nuclear Medicine,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,ChinaDepartment of Nuclear Medicine,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,ChinaDepartment of Nuclear Medicine,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,ChinaDepartment of Nuclear Medicine,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China
医药卫生
乳腺癌正电子发射断层扫描磁共振成像
breast cancerpositron emission tomographymagnetic resonance imaging
《南京医科大学学报（自然科学版）》 2026 (1)
39-46,8
国家卫生健康委核医学重点实验室项目江苏省分子核医学重点实验室项目(KF202206)
评论